Research programme: antibacterial therapeutics - Vyome BiosciencesAlternative Names: DARTSTM Therapeutics; DARTSTM antibiotics - Vyome Therapeutics
Latest Information Update: 20 Jan 2016
At a glance
- Originator Vyome Biosciences
- Class Anti-infectives
- Mechanism of Action Bacterial growth inhibitors
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
On Fast track
Fast track status is assigned by the US FDA so therapies with the potential to address unmet needs can move faster through development.
- New Molecular Entity Yes
Highest Development Phases
- Preclinical Bacterial infections
Most Recent Events
- 06 Jan 2016 Preclinical trials in Bacterial infections in India (unspecified route)
- 12 Aug 2014 Early research in Bacterial infections in India (unspecified route)